Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Inflammatory amyloidosis]

N Belmatoug1

  • 1Unité de médecine interne, Hôpital Beaujon, Clichy.

La Revue Du Praticien
|February 7, 1998
PubMed
Summary
This summary is machine-generated.

Inflammatory amyloidosis is caused by AA protein, often stemming from chronic inflammatory conditions in developed nations and infections in developing ones. It typically affects organs like the kidneys and liver, with a slow progression and potential for long survival.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Misdiagnosis of Gaucher disease in real life: Retrospective study of the French Gaucher's disease registry].

La Revue de medecine interne·2023
Same author

[Fabry disease: A review].

La Revue de medecine interne·2020
Same author

[Mucopolysaccharidosis: A review].

La Revue de medecine interne·2020
Same author

[Gaucher disease: A review].

La Revue de medecine interne·2019
Same author

Transition from pediatric to adult care in adolescents with hereditary metabolic diseases: Specific guidelines from the French network for rare inherited metabolic diseases (G2M).

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2018
Same author

Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease.

Blood cells, molecules & diseases·2017
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
Same journal

[Summary Ischemic stroke in children].

La Revue du praticien·2026
Same journal

[Treatment type 1 diabetes in children].

La Revue du praticien·2026
Same journal

[Diagnostic and therapeutic strategies for small-bowel gastrointestinal bleeding when initial upper endoscopy and colonoscopy are unremarkable].

La Revue du praticien·2026
Same journal

[Non-portal hypertension-related upper gastrointestinal bleeding].

La Revue du praticien·2026
See all related articles

Area of Science:

  • Medicine
  • Pathology
  • Rheumatology

Background:

  • Inflammatory amyloidosis is characterized by the deposition of AA protein.
  • In developed countries, causes include chronic inflammatory rheumatism (e.g., rheumatoid arthritis) and other chronic inflammatory disorders.
  • In developing countries, infectious causes like tuberculosis and leprosy are predominant.

Purpose of the Study:

  • To summarize the causes and clinical presentation of inflammatory amyloidosis.
  • To differentiate etiological factors based on geographical location (developed vs. developing countries).
  • To describe the typical organ involvement and disease course.

Main Methods:

  • Review of literature on inflammatory amyloidosis.
  • Analysis of etiological factors in developed and developing countries.

Related Experiment Videos

  • Description of common clinical manifestations and disease progression.

    • Main Results:

    • Predominant causes vary by region: chronic inflammatory rheumatism in developed countries, infections in developing countries.
    • Commonly affected organs include the kidney, liver, and gastrointestinal tract.
    • Amyloidosis onset averages 10 years after the initial disorder, with a slow, prolonged course.

    Conclusions:

    • Inflammatory amyloidosis has distinct etiological profiles in different global regions.
    • Early identification of the triggering disorder is crucial for managing amyloidosis.
    • Despite its chronic nature, prolonged survival is achievable with appropriate management.